Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Tiziana Life Sciences doses first patient in Phase 2 Alzheimer′s clinical trial (Proactive Investors) +++ TIZIANA Aktie -10,07%

VENTAS Aktie

 >VENTAS Aktienkurs 
66.96 EUR    (Tradegate)
Ask: 67.06 EUR / 450 Stück
Bid: 66.86 EUR / 450 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
VENTAS Aktie über LYNX handeln
>VENTAS Performance
1 Woche: -2,7%
1 Monat: +0,3%
3 Monate: +13,9%
6 Monate: +21,4%
1 Jahr: +17,4%
laufendes Jahr: +20,1%
>VENTAS Aktie
Name:  VENTAS INC. DL-,25
Land:  USA
Sektor:  Immobilien
ISIN/ Wkn:  US92276F1003 / 878380
Symbol/ Ticker:  VEN (Frankfurt) / VTR (NYSE)
Kürzel:  FRA:VEN, ETR:VEN, VEN:GR, NYSE:VTR
Index:  S&P500
Webseite:  https://www.ventasreit.co..
Profil:  Ventas Inc. is a leading real estate investment tr..
>Volltext..
Marktkapitalisierung:  32098.19 Mio. EUR
Unternehmenswert:  43211.07 Mio. EUR
Umsatz:  4735.07 Mio. EUR
EBITDA:  1785.04 Mio. EUR
Nettogewinn:  202.88 Mio. EUR
Gewinn je Aktie:  0.46 EUR
Schulden:  10958.03 Mio. EUR
Liquide Mittel:  206.75 Mio. EUR
Operativer Cashflow:  1325.06 Mio. EUR
Bargeldquote:  1.08
Umsatzwachstum:  9.77%
Gewinnwachstum:  -
Dividende je Aktie:  1.62 EUR
Dividendenrendite:  2.42%
Dividendenschätzung:  2.45%
Div. Historie:  30.09.25 - 0.41184€
30.06.25 - 0.41184€
>weitere anzeigen...
Insiderhandel:  2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 4.494.160 USD.
Suchwörter:  VENTAS
Letzte Datenerhebung:  17.12.25
>VENTAS Kennzahlen
Aktien/ Unternehmen:
Aktien: 469.73 Mio. St.
Frei handelbar: 99.49%
Rückkaufquote: -8.6%
Mitarbeiter: 498
Umsatz/Mitarb.: 8.47 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 9.41%
Bewertung:
KGV: 147.71
KGV lG: 159.18
KUV: 6.56
KBV: 2.97
PEG-Ratio: -
EV/EBITDA: 24.21
Rentabilität:
Bruttomarge: 19.8%
Gewinnmarge: 4.28%
Operative Marge: 15.53%
Managementeffizenz:
Gesamtkaprendite: 0.91%
Eigenkaprendite: 2.15%
>VENTAS Peer Group

Es sind 199 Aktien bekannt.
 
11.12.25 - 16:00
Key Reasons to Add Ventas Stock to Your Portfolio Right Now (Zacks)
 
VTR gains momentum as its healthcare real estate portfolio, research investments and solid balance sheet point to further growth potential....
11.12.25 - 11:48
Is Ventas Stock Outperforming the S&P 500? (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
11.12.25 - 05:39
Ventas declares $0.48 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.12.25 - 22:57
Ventas Declares Quarterly Dividend of $0.48 Per Common Share (Business Wire)
 
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.48 per common share. The dividend will be payable in cash on January 15, 2026, to stockholders of record as of the close of business on December 31, 2025. About Ventas Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OI™ platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient me...
04.12.25 - 02:02
Insiderhandel: Chairman and CEO verkauft Aktien von Ventas im Wert von 831419 USD (Insiderkauf)
 
Cafaro, Debra A. - Vorstand - Tag der Transaktion: 2025-12-01...
03.12.25 - 04:24
Ventas Subsidiary Prices Public Offering Of $500.0 Mln Of 5.000% Senior Notes Due 2036 (AFX)
 
WASHINGTON (dpa-AFX) - Ventas, Inc. (VTR) announced that its wholly owned subsidiary, Ventas Realty, Limited Partnership, has priced an underwritten public offering of $500.0 million aggregate pri......
02.12.25 - 23:33
Ventas announces pricing of $500M senior notes offering (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
02.12.25 - 23:12
Ventas Announces Pricing of Senior Notes Offering (Business Wire)
 
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that its wholly owned subsidiary, Ventas Realty, Limited Partnership (“Ventas Realty”), has priced an underwritten public offering of $500.0 million aggregate principal amount of 5.000% Senior Notes due 2036 (the “Notes”) at an issue price equal to 99.510% of the principal amount of the Notes. The Notes will be senior unsecured obligations of Ventas Realty and will be fully and unconditionally guaranteed by the Company and will mature on February 15, 2036. The sale of the Notes is expected to close on December 4, 2025, subject to the satisfaction of customary closing conditions. The Company intends to use the proceeds from the offering of the Notes for general corporate purposes, which may include repayment of other indebtedness, or any other general corporate purposes the Company may deem necessary or advisable, and to pay fees and expenses related to the offering of the Notes. Wells Fargo Secur...
28.11.25 - 19:00
Why Is Ventas (VTR) Up 7.7% Since Last Earnings Report? (Zacks)
 
Ventas (VTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
27.11.25 - 19:45
Are You Looking for a Top Momentum Pick? Why Ventas (VTR) is a Great Choice (Zacks)
 
Does Ventas (VTR) have what it takes to be a top stock pick for momentum investors? Let's find out....
21.11.25 - 03:01
Insiderhandel: EVP OM&R-Ventas/Pres&CEO-LHS verkauft Aktien von Ventas im Wert von 221701 USD (Insiderkauf)
 
Bulgarelli, Peter J. - Vorstand - Tag der Transaktion: 2025-11-18...
21.11.25 - 03:01
Insiderhandel: EVP OM&R-Ventas/Pres&CEO-LHS verkauft Aktien von Ventas im Wert von 178504 USD (Insiderkauf)
 
Bulgarelli, Peter J. - Vorstand - Tag der Transaktion: 2025-11-19...
20.11.25 - 02:02
Insiderhandel: Chairman and CEO verkauft Aktien von Ventas im Wert von 3262536 USD (Insiderkauf)
 
Cafaro, Debra A. - Vorstand - Tag der Transaktion: 2025-11-17...
18.11.25 - 19:00
Ventas Stock Rallies 16.2% in Three Months: Will It Continue to Gain? (Zacks)
 
VTR's expanding SHOP footprint, rising cash NOI and active capital recycling underscore its growth momentum....
17.11.25 - 14:03
Ventas Announces Planned Retirement of Peter J. Bulgarelli, EVP, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services (Business Wire)
 
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research and Chief Executive Officer of Lillibridge Healthcare Services, has informed the Company of his intention to retire on May 1, 2026. Ventas will commence a search process to identify a successor. “Pete has been instrumental in elevating and driving excellence across our Outpatient Medical & Research and Lillibridge businesses, benefitting the users of our exceptional environments and our shareholders,” said Ventas Chairman & CEO Debra A. Cafaro. “His leadership has helped strengthen our client and partner relationships, expand our competitive advantages and achieve industry-leading tenant satisfaction and retention. Pete has also developed a deep bench of leaders, positioning each of these businesses for growth and success. We appreciate Pete's continued engagement with the Company to ensure a smooth transition.” Bu...
15.11.25 - 02:01
Insiderhandel: EVP and CFO verkauft Aktien von Ventas im Wert von 2578845 USD (Insiderkauf)
 
Probst, Robert F. - Vorstand - Tag der Transaktion: 2025-11-12...
12.11.25 - 14:03
Insiderhandel: EVP OM&R-Ventas/Pres&CEO-LHS verkauft Aktien von Ventas im Wert von 3028 USD (Insiderkauf)
 
Bulgarelli, Peter J. - Vorstand - Tag der Transaktion: 2025-11-07...
07.11.25 - 11:12
Ventas Stock: Analyst Estimates & Ratings (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
07.11.25 - 09:02
Insiderhandel: Chairman and CEO verkauft Aktien von Ventas im Wert von 19813 USD (Insiderkauf)
 
Cafaro, Debra A. - Vorstand - Tag der Transaktion: 2025-11-06...
07.11.25 - 09:02
Insiderhandel: EVP OM&R-Ventas/Pres&CEO-LHS verkauft Aktien von Ventas im Wert von 12475 USD (Insiderkauf)
 
Bulgarelli, Peter J. - Vorstand - Tag der Transaktion: 2025-11-06...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Mensch ward zum Tun und nicht zum Vernünfteln erschaffen. Aber eben deswegen, weil er nicht dazu erschaffen ward, hängt er diesem mehr als jenem nach. - Gotthold Ephraim Lessing
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!